Latest news about Mesothelioma Lung Cancer and all Asbestos Lung Cancer related information.

MesotheliomaInNews.com -
is a resource for those seeking latest news about
Mesothelioma Asbestos Cancer and Attorneys

What Mesothelioma is?

Pleural mesothelioma is an increasingly common type of lung cancer brought on by exposure to asbestos. When inhaled, asbestos fibers become embedded in the pleura, or outer lining of the lungs, leaving behind scarring and lesions. These lesions and scars eventually develop into full-blown pleural mesothelioma, a deadly form of lung cancer for which there is no cure. Asbestos fibers can also settle in the abdominal region, triggering the development of peritoneal mesothelioma. This type of lung cancer is equally dangerous

---

Latest News

Lung Cancer Trial Targets Asbestos-Related Disease
MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos.
Read more News Source - HealthDay via Yahoo! News
Publish date - 16:03:40 07/21/08

---

Lung Cancer Trial Targets Asbestos-Related Disease
Title: Lung Cancer Trial Targets Asbestos-Related Disease Category: Health News Created: 7/22/2008 2:00:00 AM Last Editorial Review: 7/22/2008
Read more News Source - MedicineNet.com
Publish date - 19:27:46 07/22/08

---

Lung Cancer Trial Targets Asbestos-Related Disease
MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the...
Read more News Source - ABC 7 El Paso
Publish date - 15:19:08 07/22/08

---

Rosetta-based cancer test wins first approval
The New York State Department of Health has approved a test for lung cancer based on the company's microRNA technology.
Read more News Source - Globes Online
Publish date - 17:57:00 07/22/08

---

Lung Cancer Trial Targets Asbestos-Related Disease
Copyright © 2008 ScoutNews LLC. All rights reserved.
Read more News Source - HealthCentral.com
Publish date - 17:09:31 07/21/08

---

LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims
LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause. (PRWeb Jul 21, 2008) Read the full story at http://www.prweb.com/releases/2008/07/prweb1127814.htm
Read more News Source - PRWeb
Publish date - 10:10:51 07/21/08

---

LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims
LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause.
Read more News Source - PRWeb via Yahoo! News
Publish date - 08:36:08 07/21/08

---

Asbestos checks target 2 million buildings
The government plans to expand biannual checks on the management of asbestos, which can cause lung cancer, from the current 260,000 buildings to about 2 million, possibly starting next March, to cover almost all private-sector facilities nationwide, official sources said. The Land, Infrastructure, Transport and Tourism Ministry will examine with local officials the 2 million buildings to lessen ...
Read more News Source - The Japan Times
Publish date - 21:03:30 07/22/08

---

First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more News Source - Medical News Today
Publish date - 11:12:49 07/23/08

---

Rosetta Genomics Completes Acquisition Of Parkway Clinical Laboratories Inc.
Rosetta Genomics Ltd., a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Parkway Clinical Laboratories Inc., a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of ...
Read more News Source - BioresearchOnline
Publish date - 17:32:01 07/24/08

---

Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone ...
Alfacell Corporation today announced that a paper published in Molecular Cancer Therapeutics (2008; 7:1871-9) reports that a combination of ONCONASE and the thiazolidinedione antidiabetic drug rosiglitazone shows a promising effect for cancers with increased expression of PI3K-dependent Fra-1 expression or Survivin.
Read more News Source - PR Newswire via Yahoo! Finance
Publish date - 12:33:05 07/21/08

---

F1: The full verdict in Mosley's privacy case
The full verdict handed out by The Honourable Mr Justice Eady of the London High Court in the case of Max Mosley versus News of the World
Read more News Source - autosport.com
Publish date - 23:19:42 07/24/08

---

PolyMVA Health Club Launches the Largest Medical, Health, and Cancer Treatments Encyclopedia
Advanced Medicine and Research Information, PolyMVAHealthClub.com the primary distributor of Poly-MVA for Cancer patients, is announcing the release of a one of its kind, comprehensive Medical and Health Encyclopedia, largely focused on Cancer and Cancer Treatments.
Read more News Source - PRWeb via Yahoo! News
Publish date - 08:06:43 07/21/08

---

First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. announces today that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center , has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more News Source - PR Newswire via Yahoo! Finance
Publish date - 12:32:33 07/22/08

---

---